Works matching AU Pordy, Robert

Results: 28

Achievement of ESC/EAS LDL-C treatment goals after an acute coronary syndrome with statin and alirocumab.

Published in:

European Journal of Preventive Cardiology, 2022, v. 29, n. 14, p. 1842, doi. 10.1093/eurjpc/zwac107

By:

Landmesser, Ulf;
McGinniss, Jennifer;
Steg, Ph Gabriel;
Bhatt, Deepak L;
Bittner, Vera A;
Diaz, Rafael;
Dilic, Mirza;
Goodman, Shaun G;
Jukema, J Wouter;
Loy, Megan;
Pećin, Ivan;
Pordy, Robert;
Poulsen, Steen H;
Szarek, Michael;
White, Harvey D;
Schwartz, Gregory G

Publication type:

Article

Intensity of statin treatment after acute coronary syndrome, residual risk, and its modification by alirocumab: insights from the ODYSSEYOUTCOMES trial.

Published in:

European Journal of Preventive Cardiology, 2021, v. 28, n. 1, p. 33, doi. 10.1177/2047487320941987

By:

Diaz, Rafael;
Li, Qian H.;
Bhatt, Deepak L.;
Bittner, Vera A.;
Baccara-Dinet, Marie T.;
Goodman, Shaun G.;
Jukema, J. Wouter;
Takeshi Kimura;
Parkhomenko, Alexander;
Pordy, Robert;
Reiner;, Željko;
Roe, Matthew T.;
Szarek, Michael;
Hung-Fat Tse;
White, Harvey D.;
Zahger, Doron;
Zeiher, Andreas M.;
Schwartz, Gregory G.;
Steg, Ph Gabriel

Publication type:

Article

No effect of PCSK9 inhibitor alirocumab on the incidence of diabetes in a pooled analysis from 10 ODYSSEY Phase 3 studies.

Published in:

European Heart Journal, 2016, v. 37, n. 39, p. 2981, doi. 10.1093/eurheartj/ehw292

By:

Colhoun, Helen M.;
Ginsberg, Henry N.;
Robinson, Jennifer G.;
Leiter, Lawrence A.;
Müller-Wieland, Dirk;
Henry, Robert R.;
Cariou, Bertrand;
Baccara-Dinet, Marie T.;
Pordy, Robert;
Merlet, Laurence;
Eckel, Robert H.

Publication type:

Article

ODYSSEY FH I and FH II: 78 week results with alirocumab treatment in 735 patients with heterozygous familial hypercholesterolaemia.

Published in:

European Heart Journal, 2015, v. 36, n. 43, p. 2996, doi. 10.1093/eurheartj/ehv370

By:

Kastelein, John J. P.;
Ginsberg, Henry N.;
Langslet, Gisle;
Hovingh, G. Kees;
Ceska, Richard;
Dufour, Robert;
Blom, Dirk;
Civeira, Fernando;
Krempf, Michel;
Lorenzato, Christelle;
Jian Zhao;
Pordy, Robert;
Baccara-Dinet, Marie T.;
Gipe, Daniel A.;
Geiger, Mary Jane;
Farnier, Michel

Publication type:

Article

Efficacy and safety of alirocumab in high cardiovascular risk patients with inadequately controlled hypercholesterolaemia on maximally tolerated doses of statins: the ODYSSEY COMBO II randomized controlled trial.

Published in:

European Heart Journal, 2015, v. 36, n. 19, p. 1186, doi. 10.1093/eurheartj/ehv028

By:

Cannon, Christopher P.;
Cariou, Bertrand;
Blom, Dirk;
McKenney, James M.;
Lorenzato, Christelle;
Pordy, Robert;
Chaudhari, Umesh;
Colhoun, Helen M.

Publication type:

Article

Efficacy and safety of alirocumab, a fully human PCSK9 monoclonal antibody, in high cardiovascular risk patients with poorly controlled hypercholesterolemia on maximally tolerated doses of statins: rationale and design of the ODYSSEY COMBO I and II . . .

Published in:

BMC Cardiovascular Disorders, 2014, v. 14, n. 1, p. 121, doi. 10.1186/1471-2261-14-121

By:

Colhoun, Helen M.;
Robinson, Jennifer G.;
Farnier, Michel;
Cariou, Bertrand;
Blom, Dirk;
Kereiakes, Dean J.;
Lorenzato, Christelle;
Pordy, Robert;
Chaudhari, Umesh

Publication type:

Article

Efficacy and safety of alirocumab, a fully human PCSK9 monoclonal antibody, in high cardiovascular risk patients with poorly controlled hypercholesterolemia on maximally tolerated doses of statins: rationale and design of the ODYSSEY COMBO I and II trials.

Published in:

2014

By:

Colhoun, Helen M;
Robinson, Jennifer G;
Farnier, Michel;
Cariou, Bertrand;
Blom, Dirk;
Kereiakes, Dean J;
Lorenzato, Christelle;
Pordy, Robert;
Chaudhari, Umesh

Publication type:

journal article

Evinacumab in homozygous familial hypercholesterolaemia: long-term safety and efficacy.

Published in:

European Heart Journal, 2024, v. 45, n. 27, p. 2422, doi. 10.1093/eurheartj/ehae325

By:

Gaudet, Daniel;
Greber-Platzer, Susanne;
Reeskamp, Laurens F;
Iannuzzo, Gabriella;
Rosenson, Robert S;
Saheb, Samir;
Stefanutti, Claudia;
Stroes, Erik;
Wiegman, Albert;
Turner, Traci;
Ali, Shazia;
Banerjee, Poulabi;
Drewery, Tiera;
McGinniss, Jennifer;
Waldron, Alpana;
George, Richard T;
Zhao, Xue-Qiao;
Pordy, Robert;
Zhao, Jian;
Bruckert, Eric

Publication type:

Article

Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment.

Published in:

2021

By:

Schwartz, Gregory G.;
Szarek, Michael;
Bittner, Vera A.;
Bhatt, Deepak L.;
Diaz, Rafael;
Goodman, Shaun G.;
Jukema, J. Wouter;
Loy, Megan;
Manvelian, Garen;
Pordy, Robert;
White, Harvey D.;
Steg, Philippe Gabriel;
Harrington, Robert A.;
Zeiher, Andreas M.;
Tricoci, Pierluigi;
Roe, Matthew T.;
Mahaffey, Kenneth W.;
Edelberg, Jay M.;
Hanotin, Corinne;
Lecorps, Guillaume

Publication type:

journal article

Treatment With Evinacumab Links a New Pathogenic Variant in the LPL Gene to Persistent Chylomicronemia.

Published in:

Journal of the Endocrine Society, 2025, v. 9, n. 4, p. 1, doi. 10.1210/jendso/bvaf025

By:

Larouche, Miriam;
Banerjee, Poulabi;
Brisson, Diane;
Pordy, Robert;
Gaudet, Daniel

Publication type:

Article

Lower On-Treatment Low-Density Lipoprotein Cholesterol and Major Adverse Cardiovascular Events in Women and Men: Pooled Analysis of 10 ODYSSEY Phase 3 Alirocumab Trials.

Published in:

Journal of the American Heart Association, 2018, v. 7, n. 18, p. 1, doi. 10.1161/JAHA.118.009221

By:

Vallejo-Vaz, Antonio J.;
Ginsberg, Henry N.;
Davidson, Michael H.;
Eckel, Robert H.;
Cannon, Christopher P.;
Lee, L. Veronica;
Bessac, Laurence;
Pordy, Robert;
Letierce, Alexia;
Ray, Kausik K.

Publication type:

Article

Alirocumab Treatment and Achievement of Non-High-Density Lipoprotein Cholesterol and Apolipoprotein B Goals in Patients With Hypercholesterolemia: Pooled Results From 10 Phase 3 ODYSSEY Trials.

Published in:

2017

By:

Bays, Harold E.;
Leiter, Lawrence A.;
Colhoun, Helen M.;
Thompson, Desmond;
Bessac, Laurence;
Pordy, Robert;
Toth, Peter P.

Publication type:

journal article

Anti-Anginal and Anti-Ischemic Effects of Mibefradil, a New T-Type Calcium Channel Antagonist.

Published in:

Cardiology, 1998, v. 89, p. 23, doi. 10.1159/000047276

By:

Kobrin, Isaac;
Bieska, Gabriele;
Charlon, Vincent;
Lindberg, Elisabet;
Pordy, Robert

Publication type:

Article

Cilazapril with Adjunctive Hydrochlorothiazide.

Published in:

Cardiology, 1995, v. 86, n. 1, p. 41, doi. 10.1159/000176829

By:

Pordy, Robert C.

Publication type:

Article

Cilazapril plus Hydrochlorothiazide: Improved Efficacy without Reduced Safety in Mild to Moderate Hypertension.

Published in:

Cardiology, 1994, v. 85, n. 5, p. 311, doi. 10.1159/000176704

By:

Pordy, Robert C.

Publication type:

Article

Correction: Effect of alirocumab on cataracts in patients with acute coronary syndromes.

Published in:

2023

By:

Suc, Gaspard;
Schwartz, Gregory G.;
Goodman, Shaun G.;
Jukema, J. Wouter;
Manvelian, Garen;
Poulouin, Yann;
Pordy, Robert;
Scemama, Michel;
Szarek, Michael;
Steg, Ph.Gabriel

Publication type:

Correction Notice

Effect of alirocumab on cataracts in patients with acute coronary syndromes.

Published in:

BMC Ophthalmology, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12886-023-03012-1

By:

Suc, Gaspard;
Schwartz, Gregory G.;
Goodman, Shaun G.;
Jukema, J. Wouter;
Manvelian, Garen;
Poulouin, Yann;
Pordy, Robert;
Scemama, Michel;
Szarek, Michael;
Steg, Ph. Gabriel

Publication type:

Article

Effect of alirocumab on cataracts in patients with acute coronary syndromes.

Published in:

BMC Ophthalmology, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12886-023-03012-1

By:

Suc, Gaspard;
Schwartz, Gregory G.;
Goodman, Shaun G.;
Jukema, J. Wouter;
Manvelian, Garen;
Poulouin, Yann;
Pordy, Robert;
Scemama, Michel;
Szarek, Michael;
Steg, Ph. Gabriel

Publication type:

Article

Effect of proprotein convertase subtilisin/kexin type 9 inhibition on cancer events: A pooled, post hoc, competing risk analysis of alirocumab clinical trials.

Published in:

Cancer Medicine, 2023, v. 12, n. 16, p. 16859, doi. 10.1002/cam4.6310

By:

Mohammadi, Kusha A.;
Brackin, Taylor;
Schwartz, Gregory G.;
Steg, Philippe Gabriel;
Szarek, Michael;
Manvelian, Garen;
Pordy, Robert;
Fazio, Sergio;
Geba, Gregory P.

Publication type:

Article

Evinacumab: Mechanism of action, clinical, and translational science.

Published in:

CTS: Clinical & Translational Science, 2024, v. 17, n. 6, p. 1, doi. 10.1111/cts.13836

By:

Dingman, Robert;
Bihorel, Sébastien;
Gusarova, Viktoria;
Mendell, Jeanne;
Pordy, Robert

Publication type:

Article

Additional antianginal and anti-ischemic efficacy of mibefradil in patients concomitantly treated with long-acting nitrates for chronic stable angina pectoris.

Published in:

Clinical Cardiology, 1998, v. 21, n. 7, p. 483, doi. 10.1002/clc.4960210707

By:

Frishman, William H.;
Bittar, Neville;
Glasser, Stephen;
Habib, Gabriel;
Smith, William;
Pordy, Robert

Publication type:

Article

Transiently achieved very low low-density lipoprotein cholesterol levels by statin and alirocumab after acute coronary syndrome are associated with cardiovascular risk reduction: the ODYSSEY OUTCOMES trial.

Published in:

European Heart Journal, 2023, v. 44, n. 16, p. 1408, doi. 10.1093/eurheartj/ehad144

By:

Schwartz, Gregory G;
Szarek, Michael;
Bhatt, Deepak L;
Bittner, Vera A;
Bujas-Bobanovic, Maja;
Diaz, Rafael;
Fazio, Sergio;
Fras, Zlatko;
Goodman, Shaun G;
Harrington, Robert A;
Jukema, J Wouter;
Manvelian, Garen;
Pordy, Robert;
Ray, Kausik K;
Scemama, Michel;
White, Harvey D;
Steg, Ph Gabriel;
Investigators, for the ODYSSEY OUTCOMES

Publication type:

Article

Alirocumab after acute coronary syndrome in patients with a history of heart failure.

Published in:

European Heart Journal, 2022, v. 43, n. 16, p. 1554, doi. 10.1093/eurheartj/ehab804

By:

White, Harvey D;
Schwartz, Gregory G;
Szarek, Michael;
Bhatt, Deepak L;
Bittner, Vera A;
Chiang, Chern-En;
Diaz, Rafael;
Goodman, Shaun G;
Jukema, Johan Wouter;
Loy, Megan;
Pagidipati, Neha;
Pordy, Robert;
Ristić, Arsen D;
Zeiher, Andreas M;
Wojdyla, Daniel M;
Steg, Philippe Gabriel;
Investigators, for the ODYSSEY OUTCOMES

Publication type:

Article

Lipoprotein(a) lowering by alirocumab reduces the total burden of cardiovascular events independent of low-density lipoprotein cholesterol lowering: ODYSSEY OUTCOMES trial.

Published in:

European Heart Journal, 2020, v. 41, n. 44, p. 4245, doi. 10.1093/eurheartj/ehaa649

By:

Szarek, Michael;
Bittner, Vera A;
Aylward, Philip;
Baccara-Dinet, Marie;
Bhatt, Deepak L;
Diaz, Rafael;
Fras, Zlatko;
Goodman, Shaun G;
Halvorsen, Sigrun;
Harrington, Robert A;
Jukema, J Wouter;
Moriarty, Patrick M;
Pordy, Robert;
Ray, Kausik K;
Sinnaeve, Peter;
Tsimikas, Sotirios;
Vogel, Robert;
White, Harvey D;
Zahger, Doron;
Zeiher, Andreas M

Publication type:

Article

Effect of alirocumab on major adverse cardiovascular events according to renal function in patients with a recent acute coronary syndrome: prespecified analysis from the ODYSSEY OUTCOMES randomized clinical trial.

Published in:

European Heart Journal, 2020, v. 41, n. 42, p. 4114, doi. 10.1093/eurheartj/ehaa498

By:

Tuñón, José;
Steg, Philippe Gabriel;
Bhatt, Deepak L;
Bittner, Vera A;
Díaz, Rafael;
Goodman, Shaun G;
Jukema, J Wouter;
Kim, Yong-Un;
Li, Qian H;
Mueller, Christian;
Parkhomenko, Alexander;
Pordy, Robert;
Sritara, Piyamitr;
Szarek, Michael;
White, Harvey D;
Zeiher, Andreas M;
Schwartz, Gregory G;
Investigators, for the ODYSSEY OUTCOMES

Publication type:

Article

Effect of alirocumab on cardiovascular outcomes after acute coronary syndromes according to age: an ODYSSEY OUTCOMES trial analysis.

Published in:

European Heart Journal, 2020, v. 41, n. 24, p. 2248, doi. 10.1093/eurheartj/ehz809

By:

Sinnaeve, Peter R;
Schwartz, Gregory G;
Wojdyla, Daniel M;
Alings, Marco;
Bhatt, Deepak L;
Bittner, Vera A;
Chiang, Chern-En;
Flores, Roger M Correa;
Diaz, Rafael;
Dorobantu, Maria;
Goodman, Shaun G;
Jukema, J Wouter;
Kim, Yong-Un;
Pordy, Robert;
Roe, Matthew T;
Sy, Rody G;
Szarek, Michael;
White, Harvey D;
Zeiher, Andreas M;
Steg, Ph Gabriel

Publication type:

Article

Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial.

Published in:

European Heart Journal, 2019, v. 40, n. 33, p. 2801, doi. 10.1093/eurheartj/ehz299

By:

White, Harvey D;
Steg, Ph Gabriel;
Szarek, Michael;
Bhatt, Deepak L;
Bittner, Vera A;
Diaz, Rafael;
Edelberg, Jay M;
Erglis, Andrejs;
Goodman, Shaun G;
Hanotin, Corinne;
Harrington, Robert A;
Jukema, J Wouter;
Lopes, Renato D;
Mahaffey, Kenneth W;
Moryusef, Angele;
Pordy, Robert;
Roe, Matthew T;
Sritara, Piyamitr;
Tricoci, Pierluigi;
Zeiher, Andreas M

Publication type:

Article

Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia and LDL-C of 160 mg/dl or Higher.

Published in:

Cardiovascular Drugs & Therapy, 2016, v. 30, n. 5, p. 473, doi. 10.1007/s10557-016-6685-y

By:

Ginsberg, Henry;
Rader, Daniel;
Raal, Frederick;
Guyton, John;
Baccara-Dinet, Marie;
Lorenzato, Christelle;
Pordy, Robert;
Stroes, Erik

Publication type:

Article